Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

7-OH Policy Map & History

Psychedelic State(s) of America — Global Cannabis, Kratom, 7-OH, & Psychedelic Policy Tracker. Plant, fungi, and drug law and policy reform across the United States and around the world, all tracked in one place.

7-hydroxymitragynine laws and product restrictions. Natural kratom, concentrated 7-OH and synthetic products are distinct legal questions.

7-OH Policy Map & History

Unreviewed places remain neutral. A 7-OH restriction does not establish a whole-leaf kratom ban; product exemptions are recorded with each law.

Loading map…

  • Prohibited
  • Regulated framework
  • Neutral: no reviewed history

7-OH law history · 2026

  1. 1 Aug 2025 · Louisiana

    Louisiana Act 41 bans kratom including 7-OH

    Prohibited

    Signed 4 June 2025; effective 1 August. Express definition includes substances containing 7-hydroxymitragynine or mitragynine and kratom leaf derivatives. Covers possession and specified distribution/manufacture. No general whole-leaf or naturally occurring exemption.

    Louisiana R.S. 40:966.1 — Act 41